[Long-term therapy with the selective costimulation modulator CTLA4lg in rheumatoid arthritis].
Alten
R
R
Schlosspark-Klinik, Berlin. rieke.alten@schlosspark-klinik.de
D000069594:Abatacept; D000203:Activities of Daily Living / Q000145:classification; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage*; D008134:Long-Term Care; D008727:Methotrexate / Q000008:administration & dosage; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic
D018501:Antirheumatic Agents; D018796:Immunoconjugates; D000069594:Abatacept; D008727:Methotrexate